Trifecta Capital Advisors LLC Has $2.23 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Trifecta Capital Advisors LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3,625.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,533 shares of the biopharmaceutical company’s stock after purchasing an additional 2,465 shares during the […]